申请人:A. Natterman & Cie GmbH
公开号:US04643998A1
公开(公告)日:1987-02-17
The invention relates to new imidazolylalkylthienyltetrahydropyridazines of the general formula I ##STR1## their acid addition salts as well as processes for their use in the treatment of cardiovascular and/or thromboembolic illnesses in humans.
该发明涉及一般式I的新咪唑基烷基噻吩基四氢吡啶并咪唑盐的发明,以及它们在人类心血管和/或血栓栓塞疾病治疗中的应用过程。